Preterm Formula, Fortified or Unfortified Human Milk for Very Preterm Infants, the PREMFOOD Study: A Parallel Randomised Feasibility Trial
Neonatology · 2024 · 121 (2) · 222-232
DOI: 10.1159/000535498 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neonatology, online erschienen am 13.12.2023. Verfasst von Luke Mills und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chelsea and Westminster NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Milk, Human, Infant, Premature. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Objective
Uncertainty exists regarding optimal supplemental diet for very preterm infants if the mother’s own milk (MM) is insufficient. We evaluated feasibility for a randomised controlled trial (RCT) powered to detect important differences in health outcomes.
Methods
In this open, parallel, feasibility trial, we randomised infants 25+0–31+6 weeks of gestation by opt-out consent to one of three diets: unfortified human milk (UHM) (unfortified MM and/or unfortified pasteurised human donor milk (DM) supplement), fortified human milk (FHM) (fortified MM and/or fortified DM supplement), and unfortified MM and/or preterm formula (PTF) supplement from birth to 35+0 weeks post menstrual age. Feasibility outcomes included opt-outs, adherence rates, and slow growth safety criteria. We also obtained anthropometry, and magnetic resonance imaging body composition data at term and term plus 6 weeks (opt-in consent).
Results
Of 35 infants randomised to UHM, 34 to FHM, and 34 to PTF groups, 21, 19, and 24 infants completed imaging at term, respectively. Study entry opt-out rate was 38%; 6% of parents subsequently withdrew from feeding intervention. Two infants met predefined slow weight gain thresholds. There were no significant between-group differences in term total adipose tissue volume (mean [SD]: UHM: 0.870 L [0.35 L]; FHM: 0.889 L [0.31 L]; PTF: 0.809 L [0.25 L], p = 0.66), nor in any other body composition measure or anthropometry at either timepoint.
Conclusions
Randomisation to UHM, FHM, and PTF diets by opt-out consent was acceptable to parents and clinical teams, associated with safe growth profiles and no significant differences in body composition. Our data provide justification to proceed to a larger RCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chelsea and Westminster NHS Foundation Trust, London, UK.
- Section of Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
- Imperial College Healthcare NHS Trust, London, UK.
- London Northwest University Healthcare NHS Trust, London, UK.
- Croydon Health Services NHS Trust, London, UK.
Zitieren
APA
Mills, L., Chappell, K. E., Emsley, R., Alavi, A., Andrzejewska, I., Santhakumaran, S., Nicholl, R., Chang, J., Uthaya, S., & Modi, N. (2024). Preterm Formula, Fortified or Unfortified Human Milk for Very Preterm Infants, the PREMFOOD Study: A Parallel Randomised Feasibility Trial. Neonatology, 121(2), 222-232. https://doi.org/10.1159/000535498
Vancouver
Mills L, Chappell KE, Emsley R, Alavi A, Andrzejewska I, Santhakumaran S, et al. Preterm Formula, Fortified or Unfortified Human Milk for Very Preterm Infants, the PREMFOOD Study: A Parallel Randomised Feasibility Trial. Neonatology. 2024;121(2):222-232. doi:10.1159/000535498
BibTeX
@article{Mills2024,
author = {Mills, Luke and Chappell, Karyn E and Emsley, Robby and Alavi, Afshin and Andrzejewska, Izabela and Santhakumaran, Shalini and Nicholl, Richard and Chang, John and Uthaya, Sabita and Modi, Neena},
title = {Preterm Formula, Fortified or Unfortified Human Milk for Very Preterm Infants, the PREMFOOD Study: A Parallel Randomised Feasibility Trial},
journal = {Neonatology},
year = {2024},
volume = {121},
number = {2},
pages = {222--232},
doi = {10.1159/000535498}
}
EUVIMED